Editor's note: Although cancer has been recognized as a malignant disease for centuries, it has only been in the last few decades that the first molecular abnormalities underlying specific tumors have ...

Researchers are exploring new treatment options for chronic myeloid leukemia (CML). Many treatments that have recently been studied or are currently under investigation are targeted therapy drugs. CML ...

US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the number of medications already available ...

Chronic myeloid leukemia (CML) blast crisis phase is the last stage of the condition where there are large clusters of immature white blood cells, or blasts, in the bone marrow, organs, and tissue.

Chronic myeloid leukemia (CML) is a type of cancer that affects blood-forming tissues. With appropriate treatment, it is possible for people with CML to experience remission. In the 1970s, the 5-year ...

The chronic phase is the first and most treatable phase of chronic myeloid leukemia, characterized by a low percentage of abnormal cells in the blood and bone marrow. With treatment, most people in ...

The survival prognosis for patients with chronic phase CML has greatly improved since the introduction of TKIs, with some studies showing life expectancy close to the general population. Nonetheless, ...